Company: CGCT
Filing Date: 2025-03-21
Form Type: S-1/A
Source: 0001104659-25-026623
Chunk: 61

Company: Cartesian Growth Corp III
Filing Date: 2025-03-21
Form: S-1/A
Chunk 61
---
 any shares that are redeemed in connection with an initial business combination. The per share
amount we will distribute to shareholders who properly exercise their redemption rights will not be reduced by the deferred underwriting
compensation and after such redemptions, the amount held in trust will continue to reflect our obligation to pay the entire deferred
underwriting compensation. The above considerations may limit our ability to complete the most desirable business combination available
to us or optimize our capital structure. As a result, our obligations to redeem public shares for which redemption is requested and to
pay the deferred underwriting commissions may not allow us to complete the most desirable business combination or optimize our capital
structure.

In addition, raising additional third-party financing
may involve dilutive equity issuances or the incurrence of indebtedness at higher than desirable levels. Furthermore, this dilution would
increase to the extent that the anti-dilution provisions of the Class B ordinary shares result in the issuance of Class A ordinary
shares on a greater than one-to-one basis upon conversion of the Class B ordinary shares at the time of our business combination.
The above considerations may limit our ability to complete the most desirable business combination available to us or optimize our capital
structure and may result in substantial dilution from your purchase of our Class A ordinary shares. The effect of this dilution
will be greater for shareholders who do not redeem. The amount of the deferred underwriting compensation payable to the underwriters
will not be adjusted for any shares that are redeemed in connection with an initial business combination, which may further dilute your
investment. The per share amount we will distribute to shareholders who properly exercise their redemption rights will not be reduced
by the deferred underwriting compensation and after such redemptions, the per share value of shares held by non-redeeming shareholders
will reflect our obligation to pay the deferred underwriting compensation. We may not be able to generate sufficient value from the completion
of our initial business combination in order to overcome the dilutive impact of these and other factors, and, accordingly, you may incur
a net loss on your investment. Please see “— Risks Relating to Our Securities — The nominal purchase price paid by our initial shareholders for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination, and our initial shareholders are likely to make a substantial profit on their investment in us in the event we consummate an initial business combination, even if the business combination causes the trading price